StonvexLoading…
StonvexStonvexStonvexCore line items from EXPD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.07B | $10.60B | $9.30B | $17.07B |
Operating Income | $1.05B | $1.04B | $939.93M | $1.82B |
Net Income | $810.33M | $810.07M | $752.88M | $1.36B |
EPS (Diluted) | $5.95 | $5.72 | $5.01 | $8.26 |
Total Assets | $4.89B | $4.75B | $4.52B | $5.59B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.31B | $1.15B | $1.51B | $2.03B |
Free Cash Flow OCF − CapEx | $953.40M | $682.89M | $1.01B | $2.04B |
Shares Outstanding | 133.88M | 138.00M | 143.87M | 154.31M |